"COVID-19: Hotspot hospital?- Epidemiological analysis time shifted antibody tests of hospital employees

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022941

Enrollment

3000

Registered

2020-08-28

Start date

2020-06-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SARS-CoV-2 antibodies U07

Interventions

Group 1: We take one Serum sample from each voluntary participant. Everybody will get a personally report with the test result. It is possible to take part in the study repeatedly during the test peri

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: employees of the participating institutions

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
What?: We detect antibodies against SARS-CoV-2. The result will be positive or negative. When?: The period of time for taking part in the study is from June 2020 to June 2021. Each participant can decide the test time independently. It is also possible to be tested repeatedly. How?: We use the antibody test oft he Roche company.	—

Countries

Germany

Contacts

Public ContactAnke Hildebrandt

St. Vincenz Krankenhaus Datteln Klinik für Innere Medizin I

a.hildebrandt@vincenz-datteln.de+4917621979242

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026